WeVote
Log In

Bill

SH

Bill

A 4132

Prohibits certain substances in sale, distribution, and manufacture of commercial foods for human consumption.*

2024-2025 Regular Session Introduced by Shama Haider and 1 co-sponsor

New Jersey bill prohibits unnamed chemical substances in commercial foods, advancing through committee with amendments to strengthen food safety standards.

Reported out of Assembly Committee with Amendments, 2nd Reading
#food
0
WeVote Research Nonpartisan
Bill Summary · A 4132

Legislative bill overview

Assembly Bill A 4132 prohibits certain chemical substances from being used in the manufacture, sale, and distribution of commercial foods intended for human consumption in New Jersey. The bill has been amended and advanced through committee review, indicating ongoing refinement of which specific substances would be restricted. The legislation follows a model of chemical regulation in food products similar to bans already implemented in other states and the European Union.

Why is this important

Food safety regulations directly affect what products can be sold to New Jersey consumers and may influence national food manufacturing practices, as companies often reformulate products to meet the strictest state standards rather than creating separate product lines. The bill reflects growing concerns about synthetic additives and chemicals in processed foods, though the specific substances targeted remain unclear from the bill number alone. This could impact food prices, product availability, and manufacturer compliance costs depending on which chemicals are ultimately listed.

Potential points of contention

  • Specificity of banned substances: The bill's actual list of prohibited chemicals is not detailed in the summary, making it difficult to assess whether restrictions target genuinely harmful additives or substances considered safe by federal regulators (FDA).
  • Economic impact on manufacturers: Food companies may face significant reformulation costs, potentially raising consumer prices or limiting product variety, particularly for smaller producers.
  • Regulatory conflict: Substances approved by the FDA at the federal level but banned by New Jersey could create compliance complexity and state-versus-federal authority questions.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.